reported that during the second and third trimester of pregnancy, Chinese women in Shanghai, China had significantly higher levels of several gestational hormones (oestrogens, prolactin, growth hormone) than Caucasian women in Boston, USA (Lipworth et al, 1999) . The study indicates that women living in low-risk areas for breast cancer may have hormonal profiles during pregnancy that would stimulate the maturation of mammary cells to a fuller extent, as compared to women in high-risk areas.
If the authors could provide convincing evidence that the ample differences in maternal age and parity between the two populations have been taken into account appropriately, the study by Lipworth et al raise the interesting possibility that women in an area with a low incidence of breast cancer have a distinct pregnancy hormone profile characterized by higher levels of oestrogens and other mammotrophic hormones. Such hormone profile could advance the development and full maturation of breast cells making them less susceptible to carcinogenesis, as postulated by Russo et al (1982; 1994) . In this connection, it would have been of particular interest to have measured pregnancy hormones promoting breast differentiation, such as human chorionic gonadotropin (Russo et al, 1990 ) and relaxin (Bani et al, 1986) .
Maternal pregnancy hormone profiles in areas with a different incidence of breast cancer -reply

Sir
We thank Dr Akhmedkhanov and colleagues for their useful ideas about human chorionic gonodotropin and relaxin and their thoughtful and sensible biologic considerations. In particular, the idea that high levels of hormones during pregnancy might stimulate early breast cell maturation is one of the explanations we are considering for the intrauterine effects on cancer occurrence in the offspring. With respect to the issue of confounding by maternal age and parity, because the findings of higher hormone levels among Chinese women compared with Caucasian women were unexpected for us, we evaluated in detail every possible confounder, including maternal age and parity. When the data were stratified by maternal age (Table 1) or parity (Table 2) , Chinese women consistently displayed higher mean levels of the measured hormones at both visits, with the possible exception of progesterone during the second visit, as indicated in our earlier report. (Since confounding does not depend on statistical significance, and in the interest of saving space, we have not presented the confidence interval around the mean.) Thus, we can assure Dr Akhmedkhanov and colleagues, and Journal readers, that there doi: 10.1054/ bjoc.2000.1452, available online at http://www.idealibrary.com on was no effect when our results were adjusted for maternal age and parity. 
L Lipworth
levels of studied hormones at 16 and 27 completed weeks of gestation among pregnant women in Boston, USA (n = 304) and in Shanghai, China (n = 334), stratified by maternal
Sir
In a recent letter to the editor, Shamash et al (2000) argued that a raised serum lactate dehydrogenase catalytic concentration (S-LD) prior to induction chemotherapy for patients with germ cell tumours predicted a poor outcome. They referred to increasing evidence for a raised S-LD before first-line chemotherapy being as good if not better than serum human chorionic gonadotropin concentration (ShCG), as found in, e.g., International Germ Cell Cancer Collaboratory Group (IGCCCG) (von Eyben et al, 1983; Mead and Stenning, 1997) . Correspondingly, the fifth edition of the TNM (T =
